Matthew Dallos

4PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Sep 24, 2024
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer.

Casey R Ager, Aleksandar Obradovic, Patrick McCann

|Sep 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.

Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann

|Jun 14, 2021
Prostate Cancer Immunotherapy-Finally in From the Cold?

Karie D Runcie, Matthew C Dallos

Pageof 1